Annick Causse
Inserm(FR)Institut de Recherche en Cancérologie de Montpellier(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer therapeutics and mechanisms, Gastric Cancer Management and Outcomes, Colorectal and Anal Carcinomas, Cancer Mechanisms and Therapy
Most-Cited Works
- → MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy(2012)95 cited
- → Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma(2010)87 cited
- → New Topoisomerase I mutations are associated with resistance to camptothecin(2011)76 cited
- → Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump(2013)54 cited
- → At least five regions of imbalance on 6q in breast tumors, combining losses and gains(2000)52 cited
- → Novel B3GALTL mutation in Peters‐plus Syndrome(2009)21 cited
- → Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases(2001)15 cited
- → Enzyme immunoassay for human chorionic gonadotropin using monoclonal antibodies elicited with a synthetic peptide(1986)14 cited
- Human T-lymphocyte colonies: generation of colonies in different lymphocyte subpopulations.(1981)
- Quantification of ERBB2 protein expression in breast cancer: three levels of expression defined by their clinico-pathological correlations.(1994)